PROCEPT BioRobotics Corporation

US$20.62As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PRCTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (11.35%)
Div yield —
ROE (32.39%)
Medical Devices
Beta (5Y) 0.84
PE TTM —
TSR TTM (39.41%)
Mkt cap US$1.186B
ROIC (17.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$27
29.36%
(35.15%)
Hold 4|4|1|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.31
0.34
0.36
0.37
17.22%
25.07%
27.32%
30.77%
Revenue$M
106.3
105.4
103.7
104.6
(1.33%)
(1.50%)
(1.13%)
(0.37%)
Peers (US$1.186B)
Cap (US$)
PE
1.104B
46.16x
1.162B
17.03x
Capital
TTM
5Y
10Y
Leveragex
0.169
0.222
0.183
EBIT/Intx
1.377
0.454
0.439
Own earn%
17.85
37.57
30.68
Sh yield%
28.02
21.40
21.19
Owners
Insiders/Inst%
10.99
47.46
Short interest%
4.27
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
15–21
$1 testx
−0.2
Incr. ROIC%
7